Evogene Ltd. (EVGN) stock
EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
$0.34−0.05 (-13.17%)
Close on Nov 17, 2026Market cap $2.97MP/E 0.3Yield –
Evogene revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $3.85M, down 30.9% from the year before. Over ten years it grew -10.1% a year on average. The highest annual figure on record is $11.13M in fiscal 2015.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.85M | -30.9% |
| FY2024 | Dec 31, 2024 | $5.58M | +87.0% |
| FY2023 | Dec 31, 2023 | $2.98M | +78.0% |
| FY2022 | Dec 31, 2022 | $1.68M | +80.1% |
| FY2021 | Dec 31, 2021 | $930.00K | -10.6% |
| FY2020 | Dec 31, 2020 | $1.04M | +38.1% |
| FY2019 | Dec 31, 2019 | $753.00K | -56.9% |
| FY2018 | Dec 31, 2018 | $1.75M | -48.3% |
| FY2017 | Dec 31, 2017 | $3.38M | -48.3% |
| FY2016 | Dec 31, 2016 | $6.54M | -41.2% |
| FY2015 | Dec 31, 2015 | $11.13M | – |
See a number that looks wrong?